Factors affecting ACTH release from perifused equine anterior pituitary cells.
The multifactorial control of ACTH is well established. We wished to establish and characterize an in-vitro perifusion system, using equine anterior pituitary cells and physiological concentrations of secretagogues, to investigate factors which affect the dynamics of ACTH secretion. Anterior pituitary tissue was divided for dispersion into cells with collagenase, trypsin or dispase, or by mechanical dispersion. After dispersal followed by 18-h incubation, cells were perifused and the ACTH response to 10-min pulses of arginine vasopressin (AVP; 100 nmol/l), corticotrophin-releasing hormone (CRH; 0.01 nmol/l), and AVP (100 nmol/l) plus CRH (0.01 nmol/l) determined. ACTH responses to these secretagogues were lower (P < 0.05) in cells prepared using the enzymes dispase and trypsin than with the enzyme collagenase. Cells prepared by mechanical methods were not responsive. Collagenase-prepared cells were used in subsequent experiments. In dose-response studies (10-min pulse length), a steep CRH-ACTH dose-response curve was obtained with the minimum effective concentration of CRH between 0.001 and 0.01 nmol/l, and a maximum effective concentration of 1.0 nmol/l. A less steep AVP-ACTH dose-response curve was obtained with a minimum effective concentration of AVP between 0.5 and 5 nmol/l, and no plateau in response up to 5000 nmol AVP/l. Increasing the incubation time between cell preparation and stimulation with AVP from 18 h to 90 h significantly (P < 0.01) increased the ACTH response. Repeated stimulation by AVP (100 nmol/l) or CRH (0.01 nmol/l) (5-min pulses every 30 min for 23 pulses) produced ACTH responses which decreased in an approximately exponential curve with time. When AVP and CRH were given at physiological concentrations, pulse lengths and pulse frequency, the ACTH response to repeated 1-min pulses of AVP, measured as height above basal secretion, was potentiated by the addition of CRH (1, 2.5, 5, 10 and 20 pmol/l) as a constant perifusion at all AVP concentrations tested (1 nmol AVP/l, P < 0.02; 10 nmol AVP/l, P < 0.0005; 25 nmol AVP/l, P < 0.0005). During the 1-min AVP pulse, the AVP concentration at the level of the cells was 30% of the expected concentration. Potentiation was increased both by increasing AVP concentration (P < 0.00005) and by increasing CRH concentration (P < 0.00005) up to 5 pmol CRH/l. The ACTH height response to repeated AVP stimulation significantly (P = 0.034) decreased with time, independent of CRH and AVP concentration. There was a significant (P = 0.014) decrease in ACTH response to CRH infusion with time, independent of CRH concentration.(ABSTRACT TRUNCATED AT 400 WORDS)
Evans
M J
MJ
Department of Endocrinology, Christchurch Hospital, New Zealand.
Marshall
A G
AG
Kitson
N E
NE
Summers
K
K
Donald
R A
RA
D000324:Adrenocorticotropic Hormone / Q000378:metabolism*; D000818:Animals; D001127:Arginine Vasopressin / Q000494:pharmacology; D002478:Cells, Cultured; D017364:Collagenases / Q000378:metabolism; D003346:Corticotropin-Releasing Hormone / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006736:Horses; D008297:Male; D008954:Models, Biological; D010477:Perfusion; D010903:Pituitary Gland, Anterior / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*
D001127:Arginine Vasopressin; D000324:Adrenocorticotropic Hormone; D003346:Corticotropin-Releasing Hormone; D017364:Collagenases